OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Laboratory Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Blood Banking and Transfusion Medicine Challenges During the COVID-19 Pandemic	68
Panels and Syndromic Testing in Clinical Microbiology	37
Modern Blood Culture	25
Proteopathic Seed Amplification Assays for Neurodegenerative Disorders	21
Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia	19
Hemolytic Disease of the Fetus and Newborn	17
Transfusion in Neonatal Patients	16
Antibody Dynamics and Durability in Coronavirus Disease-19	16
Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification	15
Glycan Imaging Mass Spectrometry	15
Mass Cytometry, Imaging Mass Cytometry, and Multiplexed Ion Beam Imaging Use in a Clinical Setting	14
Update on Lymphoblastic Leukemia/Lymphoma	14
Breath-Based Diagnosis of Infectious Diseases	13
Platelet Transfusion	11
Update on Susceptibility Testing	11
Optimizing Genetic Diagnosis of Neurodevelopmental Disorders in the Clinical Setting	11
Transfusion Reactions and Adverse Events	11
Clinical Mass Spectrometry Approaches to Myeloma and Amyloidosis	11
Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2	11
Bringing Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging to the Clinics	11
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization	10
The Clinical Application of RNA Sequencing in Genetic Diagnosis of Mendelian Disorders	10
Clinical Pathogen Genomics	10
Point-of-Care Testing in Microbiology	10
Massive Transfusion in Pediatric Patients	10

Implementation of Mass Spectrometry Imaging in Pathology	9
Rapid Antigen Assays for SARS-CoV-2	9
Clinical Bioinformatics in Precise Diagnosis of Mitochondrial Disease	9
Enhancing Diagnosis Through RNA Sequencing	8
Breaking Through the Barrier	8
Transfusion and Cellular Therapy in Pediatric Sickle Cell Disease	8
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)	7
Performance Evaluation of Lateral Flow Assays for Coronavirus Disease-19 Serology	7
Antigen Loss after Targeted Immunotherapy in Hematological Malignancies	7
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe	6
Role of Minimal Residual Disease Testing in Acute Myeloid Leukemia	6
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States	6
Practical Challenges of Point-of-Care Testing	6
Inherited Bone Marrow Failure Syndromes	6
Artificial Intelligence Applications in Clinical Chemistry	5
Food Safety Genomics and Connections to One Health and the Clinical Microbiology Laboratory	5
Molecular Diagnostic Testing for Hematopoietic Neoplasms	5
Bioinformatics in Clinical Genomic Sequencing	5
Transfusion in Pediatric Patients	5
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity	5
Cerebrospinal Fluid Testing for Multiple Sclerosis	5
The Hematological Differential Diagnosis of Mediastinal Masses	4
Update on Acute Leukemias of Ambiguous Lineage	4
Red Blood Cell Transfusion	4
Update on Biosafety and Emerging Infections for the Clinical Microbiology Laboratory	4
Clinical Cytometry for Platelets and Platelet Disorders	4
Molecular Genetics of Pediatric Acute Myeloid Leukemia	4
Update in Infectious Disease Diagnosis in Anatomic Pathology	4
Pediatric Myelodysplastic Syndromes	4
Granulocyte Transfusion	4
Whole Blood Transfusion	4
Next-Generation Sequencing Approaches to Predicting Antimicrobial Susceptibility Testing Results	4
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays	4
Molecular Biomarkers of Response to Cancer Immunotherapy	3
Blood Group Genotyping	3
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing	3
Reactive Lymphadenopathies	3
Confounders in the Interpretation of Paraneoplastic and Neuronal Autoantibody Panels	3
Using Artificial Intelligence to Better Predict and Develop Biomarkers	3
Update in Transfusion Medicine Education	3
Analytical Principles of Cancer Next Generation Sequencing	3
Infant Acute Leukemia	3
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2	3
Therapeutic Gene Editing with CRISPR	3
Hematopathologic Correlates of CAR T-Cell Therapy	3
Precision Therapy for Inherited Retinal Disease	3